These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6720740)

  • 1. Experimental aspects of intraabdominal abscess.
    Bartlett JG
    Am J Med; 1984 May; 76(5A):91-8. PubMed ID: 6720740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis.
    Bartlett JG; Louie TJ; Gorbach SL; Onderdonk AB
    Rev Infect Dis; 1981; 3(3):535-42. PubMed ID: 7025151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative efficacy and critical interval of antimicrobial agents in experimental infections involving bacteroides fragilis.
    Bartlett JG; Dezfulian M; Joiner K
    Arch Surg; 1983 Feb; 118(2):181-4. PubMed ID: 6849635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial therapy of experimental intraabdominal sepsis.
    Weinstein WM; Onderdonk AB; Bartlett JG; Louie TJ; Gorbach SL
    J Infect Dis; 1975 Sep; 132(3):282-6. PubMed ID: 1159331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of 10 antimicrobial agents in experimental infections with Bacteroides fragilis.
    Joiner K; Lowe B; Dzink J; Bartlett JG
    J Infect Dis; 1982 Apr; 145(4):561-8. PubMed ID: 7069236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
    Wells CL; Arland LA; Simmons RL; Rotstein OD
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of abscess formation.
    Bieluch VM; Tally FP
    Clin Obstet Gynaecol; 1983 Apr; 10(1):93-103. PubMed ID: 6872404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between aerobic and anaerobic bacteria.
    Gorbach SL
    Scand J Infect Dis Suppl; 1982; 31():61-7. PubMed ID: 6954639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hyperbaric oxygenation, combined with antimicrobial agents and surgery, in a rat model of intraabdominal infection.
    Muhvich KH; Myers RA; Marzella L
    J Infect Dis; 1988 May; 157(5):1058-61. PubMed ID: 3283257
    [No Abstract]   [Full Text] [Related]  

  • 11. In-vitro susceptibility and in-vivo efficacy of antimicrobials in the treatment of intraabdominal sepsis in mice.
    Brook I; Gillmore JD
    J Antimicrob Chemother; 1993 Mar; 31(3):393-401. PubMed ID: 8486573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review. Lessons from an animal model of intra-abdominal sepsis.
    Bartlett JG; Onderdonk AB; Louie T; Kasper DL; Gorbach SL
    Arch Surg; 1978 Jul; 113(7):853-7. PubMed ID: 354591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental model of intraabdominal abscess in the rat.
    Fry DE; Garrison RN; Rink RD; Casey J; DeCamp MM; Richardson JD
    Adv Shock Res; 1982; 7():7-11. PubMed ID: 6753539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ceftriaxone plus tazobactam in a rat model of intraabdominal abscess due to Bacteroides fragilis.
    Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
    J Antimicrob Chemother; 1993 Aug; 32(2):307-12. PubMed ID: 8226433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of penicillin or ticarcillin in combination with clavulanic acid in the treatment of experimental intra-abdominal abscess.
    Bansal MB; Prabahala R; Thadepalli H
    J Antimicrob Chemother; 1986 Feb; 17(2):221-6. PubMed ID: 3700288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of rifampicin in experimental Bacteroides fragilis and Pseudomonas aeruginosa mixed infections.
    Fu KP; Lasinski ER; Zoganas HC; Kimble EF; Konopka EA
    J Antimicrob Chemother; 1985 May; 15(5):579-85. PubMed ID: 3924880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of murine intra-abdominal abscess formation.
    Cheadle WG; Hershman MJ; Pietsch JD; Logan WA; Polk HC
    Arch Surg; 1988 Nov; 123(11):1342-6. PubMed ID: 3178482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of parenteral antibiotics in the treatment of experimentally induced intraabdominal sepsis.
    Nichols RL; Smith JW; Fossedal EN; Condon RE
    Rev Infect Dis; 1979; 1(2):302-12. PubMed ID: 549185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.